I would perhaps take a little issue with the idea that funding is only provided for antibiotics if they are profitable. For pharmaceutical companies this may well be true and we could not reasonably expect otherwise. However government grants are awarded to potentially unprofitable research for, I imagine, exactly the reason that we do not wish the research that is done to be just the research that is profitable.